← Leaderboards
Pradip Raychaudhuri
University Of Illinois At Chicago
$16,086,722
Attributed
$16,867,393
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,867,393 · 11
VA$0 · 1
By mechanism
R01$16,867,393 · 11
I01$0 · 1
Top collaborators
- Srilata Bagchi5 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsTumorGenesMalignant NeoplasmsBaseApoptosisNeoplastic CellTranscription FactorTumor Suppressor ProteinsPlayPathway InteractionsMouse ModelNeoplasm MetastasisProteinsExhibitsResistanceIn VivoDna DamagePublic Health RelevanceLinkOncogenicDna RepairMalignant Neoplasm Of LiverRepression
Grant awards (77)
FoxM1 in tumor cell$0
I01 · FY2025 · VA · contact PI
Repression function of FoxM1 in metastasis$358,456
R01 · FY2023 · CA · contact PI
FoxM1 in tumor cell$0
I01 · FY2023 · VA · contact PI
Repression function of FoxM1 in metastasis$358,456
R01 · FY2022 · CA · contact PI
FoxM1 in tumor cell$0
I01 · FY2022 · VA · contact PI
Repression function of FoxM1 in metastasis$365,771
R01 · FY2021 · CA · contact PI
FoxM1 in tumor cell$0
I01 · FY2021 · VA · contact PI
Repression function of FoxM1 in metastasis$365,771
R01 · FY2020 · CA · contact PI
FoxM1 in tumor cell$0
I01 · FY2020 · VA · contact PI
Repression function of FoxM1 in metastasis$365,771
R01 · FY2019 · CA · contact PI
FoxM1 in liver cancer.$405,146
R01 · FY2018 · CA · contact PI
FoxM1 in breast cancer.$325,362
R01 · FY2018 · CA · contact PI
FoxM1 in tumor cell$0
I01 · FY2018 · VA · contact PI
FoxM1 in liver cancer.$405,146
R01 · FY2017 · CA · contact PI
FoxM1 in breast cancer.$325,362
R01 · FY2017 · CA · contact PI
FoxM1 in tumor cell$0
I01 · FY2017 · VA · contact PI
FoxM1 in liver cancer.$405,146
R01 · FY2016 · CA · contact PI
FoxM1 in breast cancer.$325,362
R01 · FY2016 · CA · contact PI
FoxM1 in tumor cell$0
I01 · FY2016 · VA · contact PI
FoxM1 in liver cancer.$405,146
R01 · FY2015 · CA · contact PI
FoxM1 in breast cancer.$325,362
R01 · FY2015 · CA · contact PI
FoxM1 in tumor cell$0
I01 · FY2015 · VA · contact PI
FoxM1 in liver cancer.$409,296
R01 · FY2014 · CA · contact PI
FoxM1 in breast cancer.$325,362
R01 · FY2014 · CA · contact PI
DNA Damage Response and DDB$306,522
R01 · FY2014 · CA · contact PI
Role of DDB in Checkpoint Control and Carcinogenesis$286,799
R01 · FY2014 · CA · contact PI
DNA Damage Response and DDB$297,042
R01 · FY2013 · CA · contact PI
Role of DDB in Checkpoint Control and Carcinogenesis$277,929
R01 · FY2013 · CA · contact PI
FoxM1 in tumor cell$0
I01 · FY2013 · VA · contact PI
DNA Damage Response and DDB$316,002
R01 · FY2012 · CA · contact PI
Role of DDB in Checkpoint Control and Carcinogenesis$295,669
R01 · FY2012 · CA · contact PI
FoxM1 in tumor cell$0
I01 · FY2012 · VA · contact PI
DNA Damage Response and DDB$316,002
R01 · FY2011 · CA · contact PI
Role of DDB in Checkpoint Control and Carcinogenesis$295,669
R01 · FY2011 · CA · contact PI
Cell Penetrating Peptide Inhibitor of FoxM1 in Hepatocellular Carcinoma Treatment$277,864
R01 · FY2011 · CA · contact PI
FoxM1 in tumor cell$0
I01 · FY2011 · VA · contact PI
DNA Damage Response and DDB$325,775
R01 · FY2010 · CA · contact PI
Cell Penetrating Peptide Inhibitor of FoxM1 in Hepatocellular Carcinoma Treatment$225,787
R01 · FY2010 · CA · contact PI
Role of DDB in Checkpoint Control and Carcinogenesis$135,473
R01 · FY2010 · CA · contact PI
Cell Penetrating Peptide Inhibitor of FoxM1 in Hepatocellular Carcinoma Treatment$286,458
R01 · FY2009 · CA · contact PI
DNA damage response and DDB$280,493
R01 · FY2009 · AG · contact PI
Cell Penetrating Peptide Inhibitor of FoxM1 in Hepatocellular Carcinoma Treatment$60,671
R01 · FY2009 · CA · contact PI
Mechanisms of Tumor Suppression by ARF$37,228
R01 · FY2009 · CA · contact PI
FoxM1 in tumor cell$0
I01 · FY2009 · VA · contact PI
Cell Penetrating Peptide Inhibitor of FoxM1 in Hepatocellular Carcinoma Treatment$286,458
R01 · FY2008 · CA · contact PI
DNA damage response and DDB$280,493
R01 · FY2008 · AG · contact PI
Mechanisms of Tumor Suppression by ARF$261,663
R01 · FY2008 · CA · contact PI
Role of damaged DNA binding protein (DDB) in checkpoint control & carcinogenesis$257,597
R01 · FY2008 · CA · contact PI
Mechanisms of Tumor Suppression by ARF$37,228
R01 · FY2008 · CA · contact PI
Cell Penetrating Peptide Inhibitor of FoxM1 in Hepatocellular Carcinoma Treatment$35,757
R01 · FY2008 · CA · contact PI
Cell Penetrating Peptide Inhibitor of FoxM1 in Hepatocellular Carcinoma Treatment$286,458
R01 · FY2007 · CA · contact PI
DNA damage response and DDB$286,218
R01 · FY2007 · AG · contact PI
Mechanisms of Tumor Suppression by ARF$261,663
R01 · FY2007 · CA · contact PI
Role of damaged DNA binding protein (DDB) in checkpoint control & carcinogenesis$257,597
R01 · FY2007 · CA · contact PI
Mechanisms of Tumor Suppression by ARF$36,260
R01 · FY2007 · CA · contact PI
Regulation of Transthyretin in the Liver$319,635
R01 · FY2006 · GM · contact PI
DNA damage response and DDB$294,766
R01 · FY2006 · AG · contact PI
Mechanisms of Tumor Suppression by ARF$269,478
R01 · FY2006 · CA · contact PI
Role of DDB in checkpoint control and carcinogenesis$265,290
R01 · FY2006 · CA · contact PI
Mechanisms of Tumor Suppression by ARF$31,200
R01 · FY2006 · CA · contact PI
DNA damage response and DDB$301,860
R01 · FY2005 · AG
Mechanisms of Tumor Suppression by ARF$275,963
R01 · FY2005 · CA
Role of DDB in checkpoint control and carcinogenesis$271,674
R01 · FY2005 · CA
ROLE OF CULLIN 4A IN TUMOR DEVELOPMENT.$227,603
R01 · FY2005 · CA
Mechanisms of Tumor Suppression by ARF$296,463
R01 · FY2004 · CA
DDB in checkpoint control and carcinogenesis$271,674
R01 · FY2004 · CA
ROLE OF CULLIN 4A IN TUMOR DEVELOPMENT.$227,603
R01 · FY2004 · CA
REGULATORS OF THE MAMMALIAN REPLICATION GENES$251,474
R01 · FY2003 · CA
ROLE OF CULLIN 4A IN TUMOR DEVELOPMENT.$227,603
R01 · FY2003 · CA
REGULATORS OF THE MAMMALIAN REPLICATION GENES$244,199
R01 · FY2002 · CA
ROLE OF CULLIN 4A IN TUMOR DEVELOPMENT.$227,603
R01 · FY2002 · CA
CELL CYCLE REGULATION BY THE HPV ONCOPROTEIN E7$118,208
R01 · FY2002 · CA
ROLE OF CULLIN 4A IN TUMOR DEVELOPMENT.$269,853
R01 · FY2001 · CA
REGULATORS OF THE MAMMALIAN REPLICATION GENES$237,141
R01 · FY2001 · CA
CELL CYCLE REGULATION BY THE HPV ONCOPROTEIN E7$115,750
R01 · FY2001 · CA
REGULATORS OF THE MAMMALIAN REPLICATION GENES$230,285
R01 · FY2000 · CA
CELL CYCLE REGULATION BY THE HPV ONCOPROTEIN E7$112,378
R01 · FY2000 · CA